Healthcare · Drug Manufacturers General · NASDAQ
| Market cap | $189.30B |
|---|---|
| Trailing P/E | — |
| FCF yield | 4.9% |
| Revenue growth (YoY) | +2.4% |
| EPS growth (YoY) | +76.8% |
| FCF/share growth (YoY) | -8.2% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Gilead Sciences, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Thomas H Tuberville | Senate | Buy | $1,001 - $15,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Buy | $1,001 - $15,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Jared Moskowitz | House | Buy | $1,001 - $15,000 | Jun 19, 2026 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Feb 26, 2026 |
| Valerie Hoyle | House | Sell | $1,001 - $15,000 | Oct 10, 2025 |
| Valerie Hoyle | House | Buy | $1,001 - $15,000 | Sep 12, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | Jun 22, 2025 |
| Marjorie Taylor Greene | House | Buy | $1,001 - $15,000 | Jun 18, 2025 |